All News #Library
Biotech
Formation Bio Licenses Anti-CD226 Program from IMIDomics
29 Jul 2025 //
PR NEWSWIRE
IMIDomics Announces Strategic Agreement with WuXi Biologics
04 Oct 2023 //
BUSINESSWIRE
IMIDomics Secures Worldwide Licensing Agreement with TNAX for TNAX101A
06 Sep 2023 //
BUSINESSWIRE

Market Place
Sourcing Support